Oxidative stress is considered the major cause of tissue injury after cerebral ischemia. The nuclear factor erythroid 2-related factor 2 (Nrf2) pathway is one of the most important defensive mechanisms against oxidative stresses and has been confirmed as a target for stroke treatment. Thus, we desired to find new Nrf2 activators and test their neuronal protective activity both in vivo and in vitro.
Results:
The herb-derived compound, Britanin, is a potent inducer of the Nrf2 system. Britanin can induce the expression of protective enzymes and reverse oxygen–glucose deprivation, followed by reperfusion (OGD-R)-induced neuronal injury in primary cortical neurons in vitro. Furthermore, the administration of Britanin significantly ameliorated middle cerebral artery occlusion–reperfusion (MCAO-R) insult in vivo. We report here the crystal structure of the complex of Britanin and the BTB domain of Keap1. Britanin selectively binds to a conserved cysteine residue, cysteine 151, of Keap1 and inhibits Keap1-mediated ubiquitination of Nrf2, leading to induction of the Nrf2 pathway.
Innovation:
Britanin is a potent inducer of Nrf2. The complex crystal structure of Britanin and the BTB domain of Keap1 help clarify the mechanism of Nrf2 induction. Britanin was proven to protect primary cortical neurons against OGD-R-induced injury in an Nrf2-dependant way. Additionally, Britanin had excellent cerebroprotective effect in an MCAO-R model.
Conclusion:
Our results demonstrate that the natural product Britanin with potent Nrf2-activating and neural protective activities both in vitro and in vivo could be developed into a cerebroprotective therapeutic agent. Antioxid. Redox Signal. 27, 754–768.
Get full access to this article
View all access options for this article.
References
1.
AlfieriA, SrivastavaS, SiowRC, CashD, ModoM, DuchenMR, FraserPA, WilliamsSC, and MannGE. Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood–brain barrier disruption and neurological deficits in stroke. Free Radic Biol Med, 65: 1012–1022, 2013.
2.
ApopaPL, HeX, and MaQ. Phosphorylation of Nrf2 in the transcription activation domain by casein kinase 2 (CK2) is critical for the nuclear translocation and transcription activation function of Nrf2 in IMR-32 neuroblastoma cells. J Biochem Mol Toxicol, 22: 63–76, 2008.
3.
BattyeTGG, KontogiannisL, JohnsonO, PowellHR, and LeslieAGW. iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM. Acta Crystallogr D Biol Crystallogr, 67: 271–281, 2011.
4.
BomprezziR. Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview. Ther Adv Neurol Disord, 8: 20–30, 2015.
5.
ChenH, YoshiokaH, KimGS, JungJE, OkamiN, SakataH, MaierCM, NarasimhanP, GoedersCE, and ChanPH. Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal, 14: 1505–1517, 2011.
6.
ChenZ-H, SaitoY, YoshidaY, SekineA, NoguchiN, and NikiE. 4-Hydroxynonenal induces adaptive response and enhances PC12 cell tolerance primarily through induction of thioredoxin reductase 1 via activation of Nrf2. J Biol Chem, 280: 41921–41927, 2005.
7.
CleasbyA, YonJ, DayPJ, RichardsonC, TickleIJ, WilliamsPA, CallahanJF, CarrR, ConchaN, KernsJK, QiH, SweitzerT, WardP, DaviesTG, and XuE. Structure of the BTB domain of Keap1 and its interaction with the triterpenoid antagonist CDDO. PLoS One, 9: e98896, 2014.
8.
CrackPJ and TaylorJM. Reactive oxygen species and the modulation of stroke. Free Radic Biol Med, 38: 1433–1444, 2005.
9.
CullinanSB, ZhangD, HanninkM, ArvisaisE, KaufmanRJ, and DiehlJA. Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival. Mol Cell Biol, 23: 7198–7209, 2003.
10.
DaoVT, CasasAI, MaghzalGJ, SeredeninaT, KaludercicN, Robledinos-AntonN, Di LisaF, StockerR, GhezziP, JaquetV, CuadradoA, and SchmidtHH. Pharmacology and clinical drug candidates in redox medicine. Antioxid Redox Signal, 23: 1113–1129, 2015.
11.
DoyleKP, SimonRP, and Stenzel-PooreMP. Mechanisms of ischemic brain damage. Neuropharmacology, 55: 310–318, 2008.
12.
EmsleyP, LohkampB, ScottWG, and CowtanK. Features and development of Coot. Acta Crystallogr D Biol Crystallogr, 66: 486–501, 2010.
13.
GaoL, WangJ, SekharKR, YinH, YaredNF, SchneiderSN, SasiS, DaltonTP, AndersonME, ChanJY, MorrowJD, and FreemanML. Novel n-3 fatty acid oxidation products activate Nrf2 by destabilizing the association between Keap1 and Cullin3. J Biol Chem, 282: 2529–2537, 2007.
14.
HongF, SekharKR, FreemanML, and LieblerDC. Specific patterns of electrophile adduction trigger Keap1 Ubiquitination and Nrf2 activation. J Biol Chem, 280: 31768–31775, 2005.
15.
HuangH-C, NguyenT, and PickettCB. Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2. Proc Natl Acad Sci U S A, 97: 12475–12480, 2000.
16.
IshiiT. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in Macrophages. J Biol Chem, 275: 16023–16029, 2000.
17.
ItohK, WakabayashiN, KatohY, IshiiT, IgarashiK, EngelJD, and YamamotoM. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev, 13: 76–86, 1999.
18.
JiangZ-Y, LuM-C, YangT-T, XiM-Y, XuX-L, GuoX-K, ZhangX-J, YouQ-D, and SunH-P. Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis. J Med Chem, 57: 2736–2745, 2014.
19.
KajtaM, LasońW, and KupiecT. Effects of estrone on N-methyl-D-aspartic acid- and staurosporine-induced changes in caspase-3-like protease activity and lactate dehydrogenase-release: time- and tissue-dependent effects in neuronal primary cultures. Neuroscience, 123: 515–526, 2004.
20.
KapposL, GoldR, MillerDH, MacManusDG, HavrdovaE, LimmrothV, PolmanCH, SchmiererK, YousryTA, YangM, EraksoyM, MeluzinovaE, RektorI, DawsonKT, SandrockAW, and O'NeillGN. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet, 372: 1463–1472, 2008.
21.
KobayashiM and YamamotoM. Nrf2-Keap1 regulation of cellular defense mechanisms against electrophiles and reactive oxygen species. Adv Enzyme Regul, 46: 113–140, 2006.
22.
LapchakPA. A critical assessment of edaravone acute ischemic stroke efficacy trials: is edaravone an effective neuroprotective therapy?. Expert Opin Pharmacother, 11: 1753–1763, 2010.
23.
LeeJ-M. Nrf2, a multi-organ protector?. FASEB J, 19: 1061–1066, 2005.
24.
LeeJ-M, ShihAY, MurphyTH, and JohnsonJA. NF-E2-related Factor-2 mediates neuroprotection against mitochondrial complex I inhibitors and increased concentrations of intracellular Calcium in primary cortical neurons. J Biol Chem, 278: 37948–37956, 2003.
25.
LiJ. Stabilization of Nrf2 by tBHQ confers protection against oxidative stress-induced cell death in human neural stem cells. Toxicol Sci, 83: 313–328, 2004.
26.
LongaEZ, WeinsteinPR, CarlsonS, and CumminsR. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke, 20: 84–91, 1989.
27.
LuoY, YangX, ZhaoS, WeiC, YinY, LiuT, JiangS, XieJ, WanX, MaoM, et al.Hydrogen sulfide prevents OGD/R-induced apoptosis via improving mitochondrial dysfunction and suppressing an ROS-mediated caspase-3 pathway in cortical neurons. Neurochem Int, 63: 826–831, 2013.
28.
MarcotteD, ZengW, HusJ-C, McKenzieA, HessionC, JinP, BergeronC, LugovskoyA, EnyedyI, CuervoH, WangD, AtemaneneC, RoechlinD, VecchiM, VivatV, KraemerJ, WinklerD, HongV, ChaoJ, LukashevM, and SilvianL. Small molecules inhibit the interaction of Nrf2 and the Keap1 Kelch domain through a non-covalent mechanism. Bioorg Med Chem, 21: 4011–4019, 2013.
29.
MeloniBP, MeadeAJ, KitikomolsukD, and KnuckeyNW. Characterisation of neuronal cell death in acute and delayed in vitro ischemia (oxygen-glucose deprivation) models. J Neurosci Methods, 195: 67–74, 2011.
30.
MurshudovGN, SkubakP, LebedevAA, PannuNS, SteinerRA, NichollsRA, WinnMD, LongF, and VaginAA. REFMAC 5 for the refinement of macromolecular crystal structures. Acta Crystallogr D Biol Crystallogr, 67: 355–367, 2011.
OguraT, TongKI, MioK, MaruyamaY, KurokawaH, SatoC, and YamamotoM. Keap1 is a forked-stem dimer structure with two large spheres enclosing the intervening, double glycine repeat, and C-terminal domains. Proc Natl Acad Sci U S A, 107: 2842–2847, 2010.
33.
QianY, GuanT, HuangM, CaoL, liY, ChengH, JinH, and YuD. Neuroprotection by the soy isoflavone, genistein, via inhibition of mitochondria-dependent apoptosis pathways and reactive oxygen induced-NF-κB activation in a cerebral ischemia mouse model. Neurochem Int, 60: 759–767, 2012.
34.
RojoAI, SagarraMR de, and CuadradoA. GSK-3β down-regulates the transcription factor Nrf2 after oxidant damage: relevance to exposure of neuronal cells to oxidative stress. J Neurochem, 105: 192–202, 2008.
35.
SatohT, OkamotoS-I, CuiJ, WatanabeY, FurutaK, SuzukiM, TohyamaK, and LiptonSA. Activation of the Keap1/Nrf2 pathway for neuroprotection by electrophillic phase II inducers. Proc Natl Acad Sci U S A, 103: 768–773, 2006.
36.
SchmidtHHHW, StockerR, VollbrachtC, PaulsenG, RileyD, DaiberA, and CuadradoA. Antioxidants in translational medicine. Antioxid Redox Signal, 23: 1130–1143, 2015.
37.
ShahZA, LiR-C, ThimmulappaRK, KenslerTW, YamamotoM, BiswalS, and DoreS. Role of reactive oxygen species in modulation of Nrf2 following ischemic reperfusion injury. Neuroscience, 147: 53–59, 2007.
38.
SurhY-J, KunduJ, and NaH-K. Nrf2 as a Master Redox Switch in Turning on the Cellular signaling involved in the induction of cytoprotective genes by some chemopreventive phytochemicals. Planta Med, 74: 1526–1539, 2008.
39.
SwansonRA, MortonMT, Tsao-WuG, SavalosRA, DavidsonC, and SharpFR. A Semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab, 10: 290–293, 1990.
WinnMD, BallardCC, CowtanKD, DodsonEJ, EmsleyP, EvansPR, KeeganRM, KrissinelEB, LeslieAGW, and McCoyA. Overview of the CCP 4 suite and current developments. Acta Crystallogr D Biol Crystallogr, 67: 235–242, 2011.
42.
XuC. Mechanism of action of isothiocyanates: the induction of ARE-regulated genes is associated with activation of ERK and JNK and the phosphorylation and nuclear translocation of Nrf2. Mol Cancer Ther, 5: 1918–1926, 2006.
43.
ZhaoJ, KoboriN, AronowskiJ, and DashPK. Sulforaphane reduces infarct volume following focal cerebral ischemia in rodents. Neurosci Lett, 393: 108–112, 2006.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
